Abstract
In 1818, the Italian Brugnatelli obtained a substance from the oxidation of uric acid that he named ossieritrico. This name, from the Greek “to make red,” referred to the property of the substance to stain the skin a characteristic red color.1 Twenty years later, the German chemists, Wöhler and Liebig, studied uric acid oxidation in detail and obtained the same compound, which they named alloxan, apparently from conflation of the words allantoin and Oxalsäure.2 The early history of alloxan has been reviewed in detail elsewhere.3 Alloxan became generally accepted as the common name for this substance. The compound as synthesized via aqueous workup is a so-called hydrate, actually a gem-diol. The systematic name of this substance is 5,5,-dihydroxy-2,4,6 (1H, 3H, 5H)-pyrimidinetrione.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Brugnatelli G. Sopra i cangiamenti che avvengono nell’ossiurico (ac. urico) trattato coll’ossisettonoso (ac. nitroso). G Fis Chim 117–29, 1818.
Wöhler F, Liebig J. Untersuchungen über die Natur der Harnsäure. Ann Pharm 26:241–340, 1838.
Lenzen S, Panten U. Alloxan: History and mechanism of action. Diabetologia 31:337–42, 1988.
Dunn JS, Sheehan HL, McLetchie NGB. Necrosis of islets of Langerhans produced experimentally. Lancet 244:484–7, 1943.
Webb JL. Alloxan. In: Enzyme and metabolic inhibitors. Webb JL, ed. Academic Press, New York, pp 367–119, 1966.
Cooperstein SJ, Watkins D. Action of toxic drugs on islet cells. In: The islet of Langerhans. Cooperstein SJ, Watkins D, eds. Academic Press, New York, pp 387–425, 1981.
Oberley LW. Free radicals and diabetes. Free Radic Biol Med 5:113–24, 1988.
Biltz H. Alloxan-anhydrid und seine Methylderivate. Ber Dtsch Chem Ges 45:3659–75, 1912.
Biilmann E, Berg N. Über die Reduktionspotentiale der Alloxantine und über die Darstellung der Alloxane und Alloxantine. Chem Ber 63:2188–204, 1930.
Brückmann G, Wertheimer E. Diabetogenic action of alloxan derivatives. Nature 155:267–8, 1945.
Hidy PH. Structural requirements for diabetogenic action in alloxan and related compounds. J Biol Chem 163:307–11, 1946.
Bernhard K, Favarger M, Renold A, Spühler O. Beiträge zur Alloxan-Glucosurie. Helv Chim Acta 30:1666–72, 1947.
Brückmann G, Wertheimer E. Alloxan studies: The action of alloxan homologues and related compounds. J Biol Chem 168:241–56, 1947.
Brückmann G, Isaacs SD. Preparation and properties of new derivatives of alloxan. J Am Chem Soc 71:390–2, 1949.
Gabathuler J. Emil Abderhalden. Sein Leben und Werk. Buchhandlung Ribaux AG, St. Gallen, pp 1–362, 1991.
Renold AE. Der Alloxan-Diabetes. Zürich, Dissertation, pp 1–45, 1948.
Lenzen S, Munday R. Thiol-group reactivity, hydrophilicity, and stability of alloxan, its reduction products and its N-methyl derivatives and a comparison with ninhydrin. Biochem Pharmacol 42:1385–91, 1991.
Munday R, Ludwig K, Lenzen S. The relationship between physicochemical properties and the biological effects of alloxan and several N-alkyl substituted alloxan derivatives. J Endocrinol 139:153–63, 1993.
Jörns A, Munday R, Tiedge M, Lenzen S. Comparative toxicity of alloxan, N-alkyl-alloxans and ninhydrin to ob/ob mouse pancreatic islets in vitro, unpublished.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Birkhäuser Boston
About this chapter
Cite this chapter
Lenzen, S., Tiedge, M., Jörns, A., Munday, R. (1996). Alloxan derivatives as a tool for the elucidation of the mechanism of the diabetogenic action of alloxan. In: Shafrir, E. (eds) Lessons from Animal Diabetes VI. Rev.Ser.Advs.Research Diab.Animals (Birkhäuser), vol 6. Birkhäuser Boston. https://doi.org/10.1007/978-1-4612-4112-6_8
Download citation
DOI: https://doi.org/10.1007/978-1-4612-4112-6_8
Publisher Name: Birkhäuser Boston
Print ISBN: 978-1-4612-8658-5
Online ISBN: 978-1-4612-4112-6
eBook Packages: Springer Book Archive